AIM
BIIB icon

abrdn Investment Management’s Biogen BIIB Stock Holding History

abrdn Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,096
Closed -$1.39M – 228
2014
Q4 		$1.39M Sell
4,096
-5,779
-59% -$1.87M 0.01% 223
2014
Q3 		$3.27M Sell
9,875
-204
-2% -$67.3K 0.01% 196
2014
Q2 		$3.18M Sell
10,079
-376
-4% -$113K 0.01% 192
2014
Q1 		$3.2M Buy
10,455
+76
+0.7% +$24.1K 0.02% 170
2013
Q4 		$2.9M Buy
10,379
+192
+2% +$49.7K 0.02% 203
2013
Q3 		$2.45M Sell
10,187
-99
-1% -$22.2K 0.01% 192
2013
Q2 		$2.21M Buy
+10,286
New +$2.2M 0.01% 186

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

abrdn Investment Management's BIIB Position: Q1 2015 in Review

abrdn Investment Management sold out of Biogen (BIIB) in Q1 2015, closing a stake of 4,096 shares — an estimated $1.39M sold.

abrdn Investment Management first reported a position in BIIB in Q2 2013 and held it in 7 quarters. The position peaked at $3.27M in Q3 2014. 966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • abrdn Investment Management reported no remaining Biogen position as of Q1 2015 after selling out during the quarter.
  • abrdn Investment Management sold 4,096 Biogen shares in Q1 2015, an estimated $1.39M.
  • abrdn Investment Management first reported a position in Biogen in Q2 2013 and held it in 7 quarters.
  • abrdn Investment Management's Biogen position peaked at $3.27M in Q3 2014.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on abrdn Investment Management's 13F filing for Q1 2015, filed 15 May 2015.